Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Meat

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jan 27, 2021 11:19am

197 Views

Post# 32398938

RE:RE:RE:Meat

Oden6570 wrote:
These US hospitals announced are for profit and will continue treatment of patients because that is their $$$$$ unlike the choice of London Ontario with 0 treated. I would expect these US hospitals will want the associated trial revenue.

Should also be less chaotic, staff less exhausted. Perhaps fewer mistakes with the protocol? And each one is a treatment center once Accelerated Approval happens. ;-)

<< Previous

Bullboard Posts

Next >>

Venture-listed mining stock reports promising drill results from Peru